Results 61 to 70 of about 9,555 (201)
A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome
Case Reports in Immunology, 2020 Sjögren’s syndrome (SS) is a chronic autoimmune disorder, often associated with some neuropsychiatric symptoms as well as systemic lupus erythematosus. Although catatonia is frequently reported in patients with systemic lupus erythematosus, it has been ...
Takahiko Inagaki +4 more
doaj +1 more source
Refractory catatonia in old age: a case report
Journal of Medical Case Reports, 2021 Background Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed. Most reports have focused on interventions and outcomes for catatonia in younger people and those with schizophrenia.
Emma Bean +3 more
doaj +1 more source
Prevalence of Mental Disorders in Parents With Intellectual Disabilities: A Systematic Review
Journal of Intellectual Disability Research, Volume 70, Issue 11, Page 1133-1150, November 2026.ABSTRACT Background Research indicates that an increasing number of adults with intellectual disabilities (IDs) are becoming parents. Parents with ID face multiple challenges that increase their mental health risks. In order to ensure better detection and tailored care for parents with ID, this systematic review aimed to summarise the prevalence of ...
Sonya Rudra +5 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2350-2356, October 2026.ABSTRACT U2 small nuclear RNA auxiliary factor 2 (U2AF2) is an essential pre‐mRNA splicing factor involved in the early stages of pre‐mRNA splicing. To date, multiple individuals have been reported with predominantly heterozygous missense variants presenting intellectual disability, speech and motor delays, seizures, hypotonia, and thin or hypoplastic ...
Amanda Toledo +3 more
wiley +1 more source
Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia
Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 277-285, October 2026.ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark +2 more
wiley +1 more source
The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry. [PDF]
PLoS ONE, 2017 The lorazepam-diazepam protocol had been proved to rapidly and effectively relieve catatonia in patients with schizophrenia or mood disorder. This study aims to investigate the efficacy of lorazepam-diazepam protocol in catatonia due to general medical ...
Chin-Chuen Lin +3 more
doaj +1 more source
Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 286-295, October 2026.ABSTRACT Objective For decades, a persistent claim has been that autobiographical memory loss after electroconvulsive therapy (ECT) for depression might actually contribute to ECT efficacy by reducing or even eliminating autobiographical memories. To test this claim, the primary aim of this study is to examine the association between autobiographical ...
Mike van Kessel +8 more
wiley +1 more source
, 2018 For the many varieties of catatonia, all medical ministrations were applied with little success until sodium Amytal (amobarbital) was shown to be specifically successful beginning in the 1930s.
Edward Shorter, Max Fink
core +1 more source
Acute Post‐Partum Psychosis and Dystonia Reveals Late‐Onset MPAN
Movement Disorders Clinical Practice, EarlyView.
Mathilde Lachaume +7 more
wiley +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Arthritis Care &Research, Volume 78, Issue 9, Page 1195-1200, September 2026.Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source